mexiletine has been researched along with Auricular Fibrillation in 14 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Experimental studies and clinical reports suggest antiarrhythmic properties of mexiletine in different arrhythmias." | 7.88 | Broad antiarrhythmic effect of mexiletine in different arrhythmia models. ( Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Garthmann, J; Köbe, J; Kochhäuser, S; Reinke, F; Wasmer, K, 2018) |
| "We describe a case of acute myocardial infarction complicated by atrial and ventricular arrhythmias in which it was possible to verify the effectiveness of lidocaine, mexiletine and propafenone." | 7.67 | Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report. ( Aguglia, F; De Marzio, P; Gnecchi, M, 1985) |
| "Disopyramide was first infused intravenously at 1 mg kg-1 for 5 min followed by a continuous infusion at 0." | 5.28 | Effects of a combination of disopyramide and mexiletine on the anterograde accessory pathway conduction in patients with Wolff-Parkinson-White syndrome. ( Aihara, N; Kamakura, S; Kurita, T; Matsuhisa, M; Ohe, T; Shimizu, W; Shimomura, K; Takaki, H, 1992) |
| "Experimental studies and clinical reports suggest antiarrhythmic properties of mexiletine in different arrhythmias." | 3.88 | Broad antiarrhythmic effect of mexiletine in different arrhythmia models. ( Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Garthmann, J; Köbe, J; Kochhäuser, S; Reinke, F; Wasmer, K, 2018) |
| "To investigate frequency dependent conduction slowing by mexiletine in the human atrium, we examined inter-atrial conduction time (IACT) at different stimulation frequencies (100/min to 220/min) in 13 patients with paroxysmal atrial fibrillation (Paf) and 7 patients without Paf." | 3.68 | [Frequency dependent prolongation of inter-atrial conduction time by mexiletine in human atrium]. ( Asayama, J; Inoue, D; Inoue, M; Ishibashi, K; Nakagawa, M; Omori, I; Sakai, R; Yamahara, Y, 1993) |
| "We describe a case of acute myocardial infarction complicated by atrial and ventricular arrhythmias in which it was possible to verify the effectiveness of lidocaine, mexiletine and propafenone." | 3.67 | Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report. ( Aguglia, F; De Marzio, P; Gnecchi, M, 1985) |
| "Mexiletine is a very well-known class IB antiarrhythmic drug, whose enantiomers differ in both pharmacodynamic and pharmacokinetic properties, the (R)-isomer being the eutomer on experimental arrhythmias and in binding studies on cardiac voltage-gated sodium channels." | 1.39 | Searching for new antiarrhythmic agents: evaluation of meta-hydroxymexiletine enantiomers. ( Bruno, C; Budriesi, R; Carocci, A; Catalano, A; Cavalluzzi, MM; Defrenza, I; Di Mola, A; Franchini, C; Lentini, G; Micucci, M, 2013) |
| "Electrocardiography (ECG) showed ventricular tachycardia." | 1.35 | A case of myotonic dystrophy presenting with ventricular tachycardia and atrial fibrillation. ( Eroğlu, S; Müderrisoğlu, H; Ozbiçer, S; Ozin, B, 2009) |
| "Disopyramide was first infused intravenously at 1 mg kg-1 for 5 min followed by a continuous infusion at 0." | 1.28 | Effects of a combination of disopyramide and mexiletine on the anterograde accessory pathway conduction in patients with Wolff-Parkinson-White syndrome. ( Aihara, N; Kamakura, S; Kurita, T; Matsuhisa, M; Ohe, T; Shimizu, W; Shimomura, K; Takaki, H, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Catalano, A | 1 |
| Budriesi, R | 1 |
| Bruno, C | 1 |
| Di Mola, A | 1 |
| Defrenza, I | 1 |
| Cavalluzzi, MM | 1 |
| Micucci, M | 1 |
| Carocci, A | 1 |
| Franchini, C | 1 |
| Lentini, G | 1 |
| Dewal, RS | 1 |
| Greer-Short, A | 1 |
| Lane, C | 1 |
| Nirengi, S | 1 |
| Manzano, PA | 1 |
| Hernández-Saavedra, D | 1 |
| Wright, KR | 1 |
| Nassal, D | 1 |
| Baer, LA | 1 |
| Mohler, PJ | 1 |
| Hund, TJ | 1 |
| Stanford, KI | 1 |
| Frommeyer, G | 1 |
| Garthmann, J | 1 |
| Ellermann, C | 1 |
| Dechering, DG | 1 |
| Kochhäuser, S | 1 |
| Reinke, F | 1 |
| Köbe, J | 1 |
| Wasmer, K | 1 |
| Eckardt, L | 1 |
| Staudacher, I | 1 |
| Seehausen, S | 1 |
| Illg, C | 1 |
| Lugenbiel, P | 1 |
| Schweizer, PA | 1 |
| Katus, HA | 1 |
| Thomas, D | 1 |
| Eroğlu, S | 1 |
| Ozin, B | 1 |
| Ozbiçer, S | 1 |
| Müderrisoğlu, H | 1 |
| El Yaman, M | 1 |
| Perry, J | 1 |
| Makielski, JC | 1 |
| Ackerman, MJ | 1 |
| Cernusková, L | 1 |
| Benes, L | 1 |
| Csöllei, J | 1 |
| Tumová, I | 1 |
| Svec, P | 1 |
| Sakai, R | 1 |
| Inoue, D | 2 |
| Ishibashi, K | 1 |
| Inoue, M | 1 |
| Omori, I | 2 |
| Yamahara, Y | 1 |
| Asayama, J | 1 |
| Nakagawa, M | 2 |
| Henning, B | 1 |
| Merx, W | 1 |
| de Bakker, JM | 1 |
| Effert, S | 1 |
| Fomina, IG | 1 |
| Iankin, VV | 1 |
| Shimizu, W | 1 |
| Ohe, T | 1 |
| Kurita, T | 1 |
| Takaki, H | 1 |
| Aihara, N | 1 |
| Kamakura, S | 1 |
| Matsuhisa, M | 1 |
| Shimomura, K | 1 |
| Aguglia, F | 1 |
| Gnecchi, M | 1 |
| De Marzio, P | 1 |
| Shirayama, T | 1 |
| Katsume, H | 1 |
| Róna, G | 1 |
1 trial available for mexiletine and Auricular Fibrillation
| Article | Year |
|---|---|
[Prospective course of therapy arresting attacks of atrial fibrillation in patients with preexcitation syndromes].
Topics: Adult; Aged; Aged, 80 and over; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; D | 1992 |
13 other studies available for mexiletine and Auricular Fibrillation
| Article | Year |
|---|---|
Searching for new antiarrhythmic agents: evaluation of meta-hydroxymexiletine enantiomers.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Guinea Pigs; Heart Atria; Mexiletine; | 2013 |
Phospho-ablation of cardiac sodium channel Na
Topics: Animals; Atrial Fibrillation; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Diet, High-Fat; Ge | 2021 |
Broad antiarrhythmic effect of mexiletine in different arrhythmia models.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disea | 2018 |
Cardiac K
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrophysiological Phenomena; Gene Expressio | 2019 |
A case of myotonic dystrophy presenting with ventricular tachycardia and atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Defibrillators, Implantable | 2009 |
Suppression of atrial fibrillation with mexiletine pharmacotherapy in a young woman with type 1 long QT syndrome.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Child; Female; Humans; Long QT Syndrome; Mexiletine | 2008 |
Carbamate analogues of tocainide.
Topics: Aconitine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Carbamates; C | 1994 |
[Frequency dependent prolongation of inter-atrial conduction time by mexiletine in human atrium].
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Electrophysiology; Female; Heart Atria; Heart Conducti | 1993 |
[The antifibrillatory effect of mexiletine (Kö 1173) in experimentally induced myocardial infarct].
Topics: Animals; Atrial Fibrillation; Disease Models, Animal; Dogs; Mexiletine; Myocardial Infarction; Propy | 1976 |
Effects of a combination of disopyramide and mexiletine on the anterograde accessory pathway conduction in patients with Wolff-Parkinson-White syndrome.
Topics: Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Disopyramide; Dose-Response Relationship, Dr | 1992 |
Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Dru | 1985 |
Mexiletine for paroxysmal atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Female; Humans; Male; Mexiletine; Middle Aged | 1988 |
[Treatment of atrial fibrillation with mexiletine in Wolff-Parkinson-White syndrome].
Topics: Adult; Aged; Atrial Fibrillation; Cardiac Pacing, Artificial; Combined Modality Therapy; Electrocard | 1986 |